Literature DB >> 22394056

Enhanced extinction of cocaine seeking in brain-derived neurotrophic factor Val66Met knock-in mice.

Lisa A Briand1, Francis S Lee, Julie A Blendy, R Christopher Pierce.   

Abstract

The Val66Met polymorphism in the brain-derived neurotropic factor (BDNF) gene results in alterations in fear extinction behavior in both human populations and mouse models. However, it is not clear whether this polymorphism plays a similar role in extinction of appetitive behaviors. Therefore, we examined operant learning and extinction of both food and cocaine self-administration behavior in an inbred genetic knock-in mouse strain expressing the variant Bdnf. These mice provide a unique opportunity to relate alterations in aversive and appetitive extinction learning as well as provide insight into how human genetic variation can lead to differences in behavior. BDNF(Met/Met) mice exhibited a severe deficit in operant learning as demonstrated by an inability to learn the food self-administration task. Therefore, extinction experiments were performed comparing wildtype (BDNF(Val/Val) ) animals to mice heterozygous for the Met allele (BDNF(Val/Met) ), which did not differ in food or cocaine self-administration behavior. In contrast to the deficit in fear extinction previously demonstrated in these mice, we found that BDNF(Val/Met) mice exhibited more rapid extinction of cocaine responding compared to wildtype mice. No differences were found between the genotypes in the extinction of food self-administration behavior or the reinstatement of cocaine seeking, indicating that the effect is specific to extinction of cocaine responding. These results suggest that the molecular mechanisms underlying aversive and appetitive extinction are distinct from one another and BDNF may play opposing roles in the two phenomena.
© 2012 The Authors. European Journal of Neuroscience © 2012 Federation of European Neuroscience Societies and Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22394056      PMCID: PMC3626276          DOI: 10.1111/j.1460-9568.2012.08021.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  74 in total

1.  The BDNF Val66Met polymorphism and anxiety: support for animal knock-in studies from a genetic association study in humans.

Authors:  Christian Montag; Ulrike Basten; Christine Stelzel; Christian J Fiebach; Martin Reuter
Journal:  Psychiatry Res       Date:  2010-05-15       Impact factor: 3.222

2.  Induction of fear extinction with hippocampal-infralimbic BDNF.

Authors:  Jamie Peters; Laura M Dieppa-Perea; Loyda M Melendez; Gregory J Quirk
Journal:  Science       Date:  2010-06-04       Impact factor: 47.728

3.  BDNF Val66Met polymorphism is associated with aggressive behavior in schizophrenia.

Authors:  G Spalletta; D W Morris; F Angelucci; I A Rubino; I Spoletini; P Bria; G Martinotti; A Siracusano; G Bonaviri; S Bernardini; C Caltagirone; P Bossù; G Donohoe; M Gill; A P Corvin
Journal:  Eur Psychiatry       Date:  2010-04-28       Impact factor: 5.361

4.  A role for alpha-adrenergic receptors in extinction of conditioned fear and cocaine conditioned place preference.

Authors:  Rick E Bernardi; K Matthew Lattal
Journal:  Behav Neurosci       Date:  2010-04       Impact factor: 1.912

5.  Cocaine-induced chromatin remodeling increases brain-derived neurotrophic factor transcription in the rat medial prefrontal cortex, which alters the reinforcing efficacy of cocaine.

Authors:  Ghazaleh Sadri-Vakili; Vidhya Kumaresan; Heath D Schmidt; Katie R Famous; Prianka Chawla; Fair M Vassoler; Ryan P Overland; Eva Xia; Caroline E Bass; Ernest F Terwilliger; R Christopher Pierce; Jang-Ho J Cha
Journal:  J Neurosci       Date:  2010-09-01       Impact factor: 6.167

6.  Stressful life events and the brain-derived neurotrophic factor gene in bipolar disorder.

Authors:  Georgina M Hosang; Rudolf Uher; Robert Keers; Sarah Cohen-Woods; Ian Craig; Ania Korszun; Julia Perry; Federica Tozzi; Pierandrea Muglia; Peter McGuffin; Anne E Farmer
Journal:  J Affect Disord       Date:  2010-02-20       Impact factor: 4.839

7.  Cell type-specific loss of BDNF signaling mimics optogenetic control of cocaine reward.

Authors:  Mary Kay Lobo; Herbert E Covington; Dipesh Chaudhury; Allyson K Friedman; HaoSheng Sun; Diane Damez-Werno; David M Dietz; Samir Zaman; Ja Wook Koo; Pamela J Kennedy; Ezekiell Mouzon; Murtaza Mogri; Rachael L Neve; Karl Deisseroth; Ming-Hu Han; Eric J Nestler
Journal:  Science       Date:  2010-10-15       Impact factor: 47.728

8.  Meta-analysis of the BDNF Val66Met polymorphism in major depressive disorder: effects of gender and ethnicity.

Authors:  M Verhagen; A van der Meij; P A M van Deurzen; J G E Janzing; A Arias-Vásquez; J K Buitelaar; B Franke
Journal:  Mol Psychiatry       Date:  2008-10-14       Impact factor: 15.992

9.  MeCP2 controls BDNF expression and cocaine intake through homeostatic interactions with microRNA-212.

Authors:  Heh-In Im; Jonathan A Hollander; Purva Bali; Paul J Kenny
Journal:  Nat Neurosci       Date:  2010-08-15       Impact factor: 24.884

10.  The BDNF Val66Met polymorphism affects HPA-axis reactivity to acute stress.

Authors:  Nina Alexander; Roman Osinsky; Anja Schmitz; Eva Mueller; Yvonne Kuepper; Juergen Hennig
Journal:  Psychoneuroendocrinology       Date:  2010-01-15       Impact factor: 4.905

View more
  7 in total

1.  Altered Oligodendrocyte Maturation and Myelin Maintenance: The Role of Antiretrovirals in HIV-Associated Neurocognitive Disorders.

Authors:  Brigid K Jensen; Hubert Monnerie; Maggie V Mannell; Patrick J Gannon; Cagla Akay Espinoza; Michelle A Erickson; Annadora J Bruce-Keller; Benjamin B Gelman; Lisa A Briand; R Christopher Pierce; Kelly L Jordan-Sciutto; Judith B Grinspan
Journal:  J Neuropathol Exp Neurol       Date:  2015-11       Impact factor: 3.685

2.  HIV Protease Inhibitors Alter Amyloid Precursor Protein Processing via β-Site Amyloid Precursor Protein Cleaving Enzyme-1 Translational Up-Regulation.

Authors:  Patrick J Gannon; Cagla Akay-Espinoza; Alan C Yee; Lisa A Briand; Michelle A Erickson; Benjamin B Gelman; Yan Gao; Norman J Haughey; M Christine Zink; Janice E Clements; Nicholas S Kim; Gabriel Van De Walle; Brigid K Jensen; Robert Vassar; R Christopher Pierce; Alexander J Gill; Dennis L Kolson; J Alan Diehl; Joseph L Mankowski; Kelly L Jordan-Sciutto
Journal:  Am J Pathol       Date:  2017-01       Impact factor: 4.307

3.  Cocaine-related behaviors in mice with deficient gliotransmission.

Authors:  Jill R Turner; Laurel E Ecke; Lisa A Briand; Philip G Haydon; Julie A Blendy
Journal:  Psychopharmacology (Berl)       Date:  2012-10-27       Impact factor: 4.530

4.  The BDNF Val66Met polymorphism enhances glutamatergic transmission but diminishes activity-dependent synaptic plasticity in the dorsolateral striatum.

Authors:  Deqiang Jing; Francis S Lee; Ipe Ninan
Journal:  Neuropharmacology       Date:  2016-07-01       Impact factor: 5.250

Review 5.  Caught in the Net: Perineuronal Nets and Addiction.

Authors:  Megan Slaker; Jordan M Blacktop; Barbara A Sorg
Journal:  Neural Plast       Date:  2016-01-19       Impact factor: 3.599

6.  Association Between Brain-Derived Neurotrophic Factor Val66Met Polymorphism and Methamphetamine Use Disorder: A Meta-Analysis.

Authors:  Li He; Yanhui Liao; Qiuxia Wu; Tieqiao Liu
Journal:  Front Psychiatry       Date:  2020-11-19       Impact factor: 4.157

7.  Current perspectives on the neurobiology of drug addiction: a focus on genetics and factors regulating gene expression.

Authors:  Jhodie R Duncan
Journal:  ISRN Neurol       Date:  2012-10-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.